By creator to www.healio.com
November 22, 2021
1 min watch
Bleyer A, et al. Summary PO0800. Introduced at: ASN Kidney Week; Nov. 2-7, 2021 (digital assembly).
Bleyer reviews serving in an advisory function for Horizon Therapeutics. Please see the examine for all different authors’ related monetary disclosures.
On this video from ASN Kidney Week, Anthony Bleyer, MD, mentioned his massive cohort examine on danger components and outcomes of gout in sufferers on dialysis.
Within the examine, Bleyer, who’s a professor of inside drugs/nephrology at Wake Forest College Faculty of Medication in Winston-Salem, North Carolina, and colleagues discovered 15% of U.S. sufferers on dialysis additionally had gout.
“What was attention-grabbing to me was the excessive degree of sufferers with gout,” Bleyer mentioned.
“As anticipated, the sufferers with gout had a better degree of many comorbid situations,” he mentioned.
— to www.healio.com